Aquestive Therapeutics, Inc. AQST Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s accrued expenses and other liabilities?
- Aquestive Therapeutics, Inc. (AQST) reported accrued expenses and other liabilities of -$2.8M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s accrued expenses and other liabilities changed year-over-year?
- Aquestive Therapeutics, Inc.'s accrued expenses and other liabilities decreased by 1.0% year-over-year, from -$2.78M to -$2.8M.